» Articles » PMID: 35646476

Assessing and Ensuring Fidelity of the Nationally Implemented English NHS Diabetes Prevention Programme: Lessons Learned for the Implementation of Large-scale Behaviour Change Programmes

Overview
Date 2022 Jun 1
PMID 35646476
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Health services interventions are typically more effective in randomised controlled trials than in routine healthcare. One explanation for this 'voltage drop', i.e. reduction in effectiveness, is a reduction in intervention fidelity, i.e. the extent to which a programme is implemented as intended. This article discusses how to optimise intervention fidelity in nationally implemented behaviour change programmes, using as an exemplar the National Health Service Diabetes Prevention Programme (NHS-DPP); a behaviour change intervention for adults in England at increased risk of developing Type 2 diabetes, delivered by four independent provider organisations. We summarise key findings from a thorough fidelity evaluation of the NHS-DPP assessing design (whether programme plans were in accordance with the evidence base), training (of staff to deliver key intervention components), delivery (of key intervention components), receipt (participant understanding of intervention content), and highlight lessons learned for the implementation of other large-scale programmes.

Results: NHS-DPP providers delivered the majority of behaviour change content specified in their programme designs. However, a drift in fidelity was apparent at multiple points: from the evidence base, during programme commissioning, and on to providers' programme designs. A lack of clear theoretical rationale for the intervention contents was apparent in design, training, and delivery. Our evaluation suggests that many fidelity issues may have been less prevalent if there was a clear underpinning theory from the outset.

Conclusion: We provide recommendations to enhance fidelity of nationally implemented behaviour change programmes. The involvement of a behaviour change specialist in clarifying the theory of change would minimise drift of key intervention content. Further, as loss of fidelity appears notable at the design stage, this should be given particular attention. Based on these recommendations, we describe examples of how we have worked with commissioners of the NHS-DPP to enhance fidelity of the next roll-out of the programme.

Citing Articles

Assessing multidimensional fidelity in a pilot optimization trial: A process evaluation of four intervention components supporting medication adherence in women with breast cancer.

Green S, Graham C, Collinson M, Loo Ow P, Hall L, French D Transl Behav Med. 2024; 15(1.

PMID: 39657026 PMC: 11756324. DOI: 10.1093/tbm/ibae066.


Enhancing postpartum cardiometabolic health for women with previous gestational diabetes: Next steps and unanswered questions for pharmacological and lifestyle strategies.

Golubic R, Car J, Nicolaides K Diabetes Obes Metab. 2024; 27(2):447-449.

PMID: 39552532 PMC: 11701171. DOI: 10.1111/dom.16070.


The challenges and lessons from a formative process and value-based evaluation of the wave 1 roll-out of the all Wales Diabetes Prevention Programme.

Parsons S, Kosnes L, Anderson P, Harris S, Thatcher R, Harrington B BMC Public Health. 2024; 24(1):2499.

PMID: 39272010 PMC: 11401378. DOI: 10.1186/s12889-024-19946-0.


Acceptability, fidelity and trial experience of four intervention components to support medication adherence in women with breast cancer: A process evaluation protocol for a pilot fractional factorial trial.

Green S, Hall L, Rousseau N, French D, Graham C, Collinson M NIHR Open Res. 2023; 3:3.

PMID: 37881449 PMC: 10593334. DOI: 10.3310/nihropenres.13337.2.


Engagement with a nationally-implemented digital behaviour change intervention: Usage patterns over the 9-month duration of the National Health Service Digital Diabetes Prevention Programme.

Hawkes R, Miles L, Ainsworth B, Ross J, Meacock R, French D Internet Interv. 2023; 33:100647.

PMID: 37502122 PMC: 10368926. DOI: 10.1016/j.invent.2023.100647.


References
1.
Aziz Z, Absetz P, Oldroyd J, Pronk N, Oldenburg B . A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implement Sci. 2015; 10:172. PMC: 4681022. DOI: 10.1186/s13012-015-0354-6. View

2.
Toomey E, Hardeman W, Hankonen N, Byrne M, McSharry J, Matvienko-Sikar K . Focusing on fidelity: narrative review and recommendations for improving intervention fidelity within trials of health behaviour change interventions. Health Psychol Behav Med. 2021; 8(1):132-151. PMC: 8114368. DOI: 10.1080/21642850.2020.1738935. View

3.
Skivington K, Matthews L, Simpson S, Craig P, Baird J, Blazeby J . A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021; 374:n2061. PMC: 8482308. DOI: 10.1136/bmj.n2061. View

4.
French D, Hawkes R, Bower P, Cameron E . Is the NHS Diabetes Prevention Programme Intervention Delivered as Planned? An Observational Study of Fidelity of Intervention Delivery. Ann Behav Med. 2021; 55(11):1104-1115. PMC: 8557367. DOI: 10.1093/abm/kaaa108. View

5.
Dunkley A, Bodicoat D, Greaves C, Russell C, Yates T, Davies M . Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014; 37(4):922-33. DOI: 10.2337/dc13-2195. View